Elisabeth Leiderman
Director/Board Member at BLUEBIRD BIO, INC.
Net worth: 20 320 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Lindsay Rosenwald | M | 68 | 15 years | |
| Andrew Obenshain | M | 51 | 8 years | |
| Christopher Krawtschuk | M | 51 | 2 years | |
| Martin Pulé | M | 51 | 10 years | |
| Martin Murphy | M | 55 | 10 years | |
| Mark Vachon | M | 65 | 10 years | |
| Christian Itin | M | 59 | 10 years | |
| Nick Leschly | M | 51 | 14 years | |
| Linda Bain | F | 53 | 6 years | |
| David Brochu | M | - | 5 years | |
| Richard Colvin | M | 58 | 6 years | |
| Alex Driggs | M | 48 | - | |
| Alexander Swan | M | - | 3 years | |
| Michael Weiss | M | 58 | 11 years | |
| John Agwunobi | M | 59 | 7 years | |
| Olivia Manser | F | - | 2 years | |
| Najoh Tita | F | - | 3 years | |
| Charlotte Jones-Burton | M | - | 2 years | |
| Richard Paulson | M | 56 | 1 years | |
| Joseph Anderson | M | 65 | 8 years | |
| Dov Klein | M | 72 | 9 years | |
| Malcolm Hoenlein | M | 80 | 10 years | |
| Cynthia Butitta | F | 70 | 6 years | |
| Thomas Klima | M | 52 | 3 years | |
| Jimmie Harvey | M | 72 | 16 years | |
| John Berriman | M | 76 | 10 years | |
| Andrea Walton | F | - | 2 years | |
| Brent Rice | M | 58 | 3 years | |
| Jess Rowlands | F | - | 2 years | |
| Melissa Bonner | M | - | 3 years | |
| Veronica Hersberger | M | - | 1 years | |
| Sarah Alspach | F | - | 3 years | |
| Julia Wilson | F | - | - | |
| Robert Iannone | M | 57 | 1 years | |
| Courtney OLeary | F | - | - | |
| Anne-Virginie Eggimann | M | 51 | 13 years | |
| Christopher Vann | M | 59 | 8 years | |
| Elizabeth Pingpank | F | - | 8 years | |
| Robert Azelby | M | 56 | - | |
| George Avgerinos | M | 71 | 11 years | |
| Robert Dolski | M | 54 | 1 years | |
| Joseph Vittiglio | M | 52 | 1 years | |
| William Young | M | 79 | 3 years | |
| Eric Rowinsky | M | 67 | 14 years | |
| Miranda Neville | F | - | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jason Cole | M | 51 | 8 years | |
| Robyn Hunter | F | 62 | 11 years | |
| Gina Consylman | F | 52 | 1 years | |
| Glenn L. Cooper | M | 71 | 4 years | |
| Harlan Weisman | M | 71 | 1 years | |
| Bobby Sandage | M | 70 | 2 years | |
| Raymond Tesi | M | 68 | 3 years | |
| Francisco Salva | M | 53 |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 2 years |
| Noah Beerman | M | 62 | 2 years | |
| Joshua M. Tarnoff | M | 60 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 7 years |
| Ramy Ibrahim | M | 49 | - | |
| Alison Finger | F | 60 | 2 years | |
| Denice Torres | F | 64 | 1 years | |
| William R. Sellers | M | 63 | 2 years | |
| Ravichandran Rao | M | - |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 1 years |
| Matthew Foy | M | - | - | |
| Katherine Edna Breedis | F | 61 | - | |
| Ronald Vigliotta | M | 51 | 5 years | |
| Chip Baird | M | 52 | 2 years | |
| Helen C. Fu | F | - | - | |
| Sara Nochur | M | 63 | 2 years | |
| Kapil Dhingra | M | 64 | 9 years | |
| Daniel Lynch | M | 65 | 10 years | |
| Xiao Qin Lu | M | 49 | 5 years | |
| Michael Rogers | M | 64 | 2 years | |
| Cynthia Hu | M | 54 | 2 years | |
| Christine Poon | F | 71 | 2 years | |
| James Murphy | M | 67 | 1 years | |
| Wendy Dixon | M | 68 | 8 years | |
| Peter Thompson | M | 64 | 3 years | |
| Dale Ritter | M | 73 | 2 years | |
| William Carson | M | 65 | 2 years | |
| David Barrett | M | 48 | - | |
| Gary Gemignani | M | 58 | 1 years | |
| John Johnson | M | 66 | 3 years | |
| Edgar Braendle | M | - | 3 years | |
| Evan Renov | M | - | 2 years | |
| Dorota McKay | F | 42 | - | |
| Rafael Rizo-Patron | M | - |
Nomura Securities, Inc.
| 6 years |
| Daniel Mamadou Blanco | M | 53 |
Nomura Securities, Inc.
| 3 years |
| Elizabeth A. Tarka | M | 57 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 2 years |
| Marcela Maus | M | 48 | - | |
| Gilles Nobécourt | M | 67 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | - |
| Sarah Glickman | F | 54 | 1 years | |
| Jessica Whitten | F | 48 | 3 years | |
| Mark T. Battaglini | M | - | - | |
| Anthony Philippakis | M | 48 | 3 years | |
| Ben Machielse | M | - |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | - |
| Kathleen Wilkinson | F | 52 | 9 years | |
| Murat Omur | M | 46 |
Nomura Securities, Inc.
| 4 years |
| Kevin J. Horgan | M | 64 | 1 years | |
| Diane Jorkasky | M | 72 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | 5 years |
| Sara Nayeem | M | 75 |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | - |
| Karin Hehenberger | M | 52 | 2 years | |
| Jenny Marlowe | M | 47 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 77 | 77.00% |
| United Kingdom | 23 | 23.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Elisabeth Leiderman
- Personal Network
